REG - IQ-AI Limited - AGM Statement

IQ-AIAnnouncement

23/05/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230523:nRSW2406Aa&default-theme=true

RNS Number : 2406A  IQ-AI Limited  23 May 2023

 

IQ-AI Limited

("IQ-AI" or the "Company")

 

AGM Statement

 

IQ-AI Limited is due to hold its AGM today. At the AGM, the Chairman will
announce the following:

 

•             Over 200 more datasets have been received in
collaboration with Phoenix Children's Hospital. These datasets will be used
for the continued development of Artificial Intelligence (AI) imaging
technologies targeted to aid pediatric patients. Quality training data
improves AI performance and the AI models already in development for adult
patients can easily be trained using pediatric datasets.

 

•             The Phase I clinical trial maintains strong
momentum, enrolling subjects at the final dose level and into the expansion
phase (where a larger number of patients are treated to further assess the
safety of the final dose).

 

•             In the USA, May is recognized as Brain Tumor
Awareness month; a month dedicated to raising awareness. In support of this
initiative, a local (Wisconsin, USA) TV outlet will interview Dr. Jennifer
Connelly later this month to showcase the Phase I Clinical Trial being
conducted at the Medical College of Wisconsin. Joining Dr. Connelly will be
one of the trial participants.

 

•             Following a successful appearance at the ASNR
(American Society of Neuroradiology) conference in Chicago earlier this month,
Imaging Biometrics LLC ("IB") is exploring two academic collaborations for the
commercialization of novel and emerging imaging technologies.

 

•             A product development milestone was met for
enabling longitudinal reporting capabilities. This accomplishment lays the
foundation for reporting of IB's quantitative output over time to assess
treatment response in patients.

 

Trevor Brown, Chair said "Progress continues steadily across all activities as
prospects continue to brighten. I am looking forward to updating shareholders
as the year unfolds."

 

 

 

The Directors of the Company accept responsibility for the contents of this
announcement.

 

 

 

-ENDS-

 

For further information, please contact:

 

 IQ-AI Limited

 Trevor Brown/Brett Skelly/Vinod Kaushal

 Tel: 020 7469 0930

 Peterhouse Capital Limited (Financial Adviser and Broker)

 Lucy Williams/Heena Karani

 Tel: 020 7220 9797

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGMBSGDUCDDDGXD